Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Debt Ratio (2017 - 2021)

Historic Debt Ratio for Sunshine Biopharma (SBFM) over the last 5 years, with Q4 2021 value amounting to 0.86.

  • Sunshine Biopharma's Debt Ratio fell 498.22% to 0.86 in Q4 2021 from the same period last year, while for Dec 2021 it was 0.86, marking a year-over-year decrease of 498.22%. This contributed to the annual value of 0.86 for FY2021, which is 498.22% down from last year.
  • According to the latest figures from Q4 2021, Sunshine Biopharma's Debt Ratio is 0.86, which was down 498.22% from 1.28 recorded in Q3 2021.
  • In the past 5 years, Sunshine Biopharma's Debt Ratio registered a high of 1.28 during Q3 2021, and its lowest value of 0.19 during Q3 2019.
  • In the last 5 years, Sunshine Biopharma's Debt Ratio had a median value of 0.31 in 2017 and averaged 0.59.
  • Its Debt Ratio has fluctuated over the past 5 years, first plummeted by 3350.34% in 2019, then skyrocketed by 14764.36% in 2021.
  • Sunshine Biopharma's Debt Ratio (Quarter) stood at 0.31 in 2017, then dropped by 12.46% to 0.27 in 2018, then crashed by 30.55% to 0.19 in 2019, then soared by 382.31% to 0.91 in 2020, then fell by 4.98% to 0.86 in 2021.
  • Its Debt Ratio was 0.86 in Q4 2021, compared to 1.28 in Q3 2021 and 1.13 in Q2 2021.